XPANCEO: Bionic Contact Lenses Merging Vision, Health, and Augmented Reality
At the Mobile World Congress 2025 in Barcelona, the Dubai-based startup XPANCEO presented a series of prototypes of bionic contact lenses that have the potential to redefine the future of wearable technology. These devices combine augmented reality functions, health monitoring, and biometric measurements, offering users a unique way to interact with the digital world.
One of the showcased prototypes is a contact lens with a wireless power supply system. It is equipped with a miniature projector and receives power from a compact external device resembling a lens case. This solution allows the lens to remain lightweight and flexible while ensuring stable operation without the need for wires or bulky batteries.

Another prototype is a biosensing lens capable of analyzing the composition of tear fluid. Using nanoparticles, it detects and measures levels of glucose, hormones (such as cortisol and testosterone), and vitamins (B1, B2, B3, E, and D). This enables continuous health monitoring without the need for invasive procedures.
A third prototype is designed to measure intraocular pressure, which is particularly important for early detection of glaucoma. The lens contains an optical pattern that changes depending on the pressure inside the eye. With the help of a smartphone and a dedicated app, the user can receive accurate real-time data, facilitating timely diagnosis and treatment.
Additionally, XPANCEO demonstrated lenses with integrated microdisplays for showing information directly in the user’s field of vision, as well as lenses capable of wirelessly transmitting data to external devices. All of these developments aim to create a unified device that merges the functions of a smartphone, fitness tracker, and AR glasses into the form factor of a contact lens.
The company plans to complete the development of a fully functional prototype by the end of 2026. If successful, XPANCEO may become a pioneer in the field of bionic contact lenses, opening new horizons for personalized medicine and augmented reality.

